SMS Lifesciences India Ltd - 540679 - Clarification sought from SMS Lifesciences India Ltd
The Exchange has sought clarification from SMS Lifesciences India Ltd on April 17th, 2020, with reference to Movement in Price.The reply is awaited. SMS Lifesciences India Ltd - 540679 - UPDATE ON RANITIDINE HCL
News about Ranitidine formulations in the US. SMS Lifesciences India Ltd - 540679 - Closure of Trading Window
Trading window for all Directors, Promoters, Designated Employees and Specified Connected Persons w.e.f. April 1, 2020 to 48 hours after the declaration of financial results. Board Meeting for approval of financial results will be held on or before June 30, 2020 as per SEBI circular no. SEBI/HO/CFD/CMD1/CIR/P/2020/3 dated March 19, 2020. SMS Lifesciences India Ltd - 540679 - Disclosure Under Reg. 7(2) Of SEBI (PIT) Regulations, 2015 And Reg. 29(2) Of SEBI (SAST) Regulations, 2011
Mrs. T Annapurna has purchased 1,50,000 equity share (4.96%) and Mrs. Hima Bindu Potluri has sold 1,50,000 equity share (4.96%), on March 6, 2020 through open market. SMS Lifesciences India Ltd - 540679 - "INDIA PHARMA BULK DRUG COMPANY OF THE YEAR AWARD"
Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020 Conference held on March 5, 2020. SMS Lifesciences India Ltd - 540679 - REPORTING UNDER REGULATION 29(2) OF SEBI (SAST) REGULATIONS, 2011 READ WITH REGULATION 7(2) OF SEBI (PIT) REGULATIONS, 2015
Mr. Trllok Potluri has acquired 27,032 equity shares (0.89%) from Mrs. Satyavani Potluru by gift transfer. SMS Lifesciences India Ltd - 540679 - Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to subject cited above, we are herewith enclosing the copies of advertisement issued in newspapers on February 16, 2020 in ''Financial Express'' in English language and in ''Andhra Prabha'' in Telugu language, with respect to Un-audited Standalone and Consolidated Financial Results for the third quarter and nine months ended as on December 31, 2019. SMS Lifesciences India Ltd - 540679 - Appointment of Company Secretary and Compliance Officer
Mr. Trupti Ranjan Mohanty (A60358) is appointed as the Company Secretary and Compliance officer of the Company w.e.f. February 14, 2020. SMS Lifesciences India Ltd - 540679 - Unaudited Financial Results (Standalone And Consolidated) For The Thrid Quarter And Nine Months Ended December 31, 2019
Unaudited Financial Results for the quarter and nine months ended December 31, 2019 and appointment of Mr. trupti Ranjan Mohanty as Company Secretary and Compliance Officer. SMS Lifesciences India Ltd - 540679 - Board Meeting Intimation for Considering And Approving The Q3 Unaudited Financial Results (Standalone & Consolidated)
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2020 ,inter alia, to consider and approve Consideration of Un-audited Financial Results of the Company for the third quarter ended December 31, 2019.